|
rs61816761
|
|
Eczema
|
A |
0.900 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs886041094
|
|
Eczema
|
A |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs886039903
|
|
Eczema
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs780533096
|
|
Eczema
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs759191907
|
|
Eczema
|
G |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs397514698
|
|
Eczema
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs387906760
|
|
Eczema
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs374052333
|
|
Eczema
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs200473652
|
|
Eczema
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs1555549674
|
|
Eczema
|
G |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs1555548678
|
|
Eczema
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs1555483699
|
|
Eczema
|
T |
0.700 |
GeneticVariation
|
CLINVAR |
|
|
|
|
rs1554236040
|
|
Eczema
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs114925667
|
|
Eczema
|
A |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
|
rs555743307
|
|
Eczema
|
|
0.040 |
GeneticVariation
|
BEFREE |
To assess whether genetic variants of TXA2 receptor, IL-4 and IL-4R alpha genes relate to the elevation of serum immunoglobulin E levels in patients with atopic dermatitis (AD), we conducted an association study of genetic polymorphisms of TXA2 receptor (795C/T), IL-4 (-589C/T), and IL-4R alpha (Ile50Val) in a Japanese population (n = 789).
|
11922633 |
2002 |
|
rs2303067
|
|
Eczema
|
|
0.070 |
GeneticVariation
|
BEFREE |
These results suggest that SPINK5 Glu420Lys polymorphism may be associated with certain asthma phenotypes characterized by the concomitant expression of asthma and atopic dermatitis or SPT reactivity.
|
15005725 |
2004 |
|
rs2228428
|
|
Eczema
|
|
0.010 |
GeneticVariation
|
BEFREE |
C1014T SNP of CCR4 does not appear to be associated with susceptibility to atopic dermatitis in Japanese patients.
|
15202833 |
2004 |
|
rs2303067
|
|
Eczema
|
|
0.070 |
GeneticVariation
|
BEFREE |
We investigated whether single nucleotide polymorphisms in SPINK5 (ie, -785 A/G, Asn368Ser, and Lys420Glu) are associated with asthma, atopic phenotypes, and atopic dermatitis in 200 families ascertained by a proband with asthma (nonaffected spouses served as a matched control population) and an independent set of 252 trios with asthma.
|
15753894 |
2005 |
|
rs2303063
|
|
Eczema
|
|
0.020 |
GeneticVariation
|
BEFREE |
We investigated whether single nucleotide polymorphisms in SPINK5 (ie, -785 A/G, Asn368Ser, and Lys420Glu) are associated with asthma, atopic phenotypes, and atopic dermatitis in 200 families ascertained by a proband with asthma (nonaffected spouses served as a matched control population) and an independent set of 252 trios with asthma.
|
15753894 |
2005 |
|
rs2303067
|
|
Eczema
|
|
0.070 |
GeneticVariation
|
BEFREE |
The Glu420Lys variant showed significant association with atopy, asthma and atopic dermatitis in recent studies.
|
15820494 |
2005 |
|
rs2569193
|
|
Eczema
|
|
0.010 |
GeneticVariation
|
BEFREE |
In dominant models adjusted for potential confounders, SNP rs2569193 was associated with significantly decreased risk for eczema (odds ratio [OR] for CT/TT vs CC, 0.5; 95% CI, 0.3-0.8), whereas SNP rs2569190 (also reported as the C-159T) was associated with significantly increased risk for eczema (OR for CT/TT vs CC, 2.3; 95% CI, 1.4-3.8).
|
15867866 |
2005 |
|
rs2569190
|
|
Eczema
|
|
0.010 |
GeneticVariation
|
BEFREE |
In dominant models adjusted for potential confounders, SNP rs2569193 was associated with significantly decreased risk for eczema (odds ratio [OR] for CT/TT vs CC, 0.5; 95% CI, 0.3-0.8), whereas SNP rs2569190 (also reported as the C-159T) was associated with significantly increased risk for eczema (OR for CT/TT vs CC, 2.3; 95% CI, 1.4-3.8).
|
15867866 |
2005 |
|
rs436857
|
|
Eczema
|
|
0.010 |
GeneticVariation
|
BEFREE |
In a case-control association study, we found that promoter polymorphisms -111A/T and -2C/T were significantly associated with an increased risk of AD under a recessive model.
|
16159888 |
2005 |
|
rs5743810
|
|
Eczema
|
|
0.010 |
GeneticVariation
|
BEFREE |
Genotyping of the Ser249Pro polymorphism in 68 unrelated adult patients and 132 unrelated children with asthma, 185 unrelated patients with COPD, 295 unrelated individuals with AD and 212 healthy control subjects was performed by restriction enzyme digestion.
|
16188043 |
2005 |
|
rs895691
|
|
Eczema
|
|
0.010 |
GeneticVariation
|
BEFREE |
In the MRC-E panel, rs895691, between the end of exon 6 of SLC9A3R1 and exon 7 of NAT9, was associated with AD (P = 0.037).
|
16374479 |
2006 |